tradmap

DAIO DATA I/O CORP

$2.43 +3.40%

Data as of close

Healthcare · Instruments For Meas & Testing Of Electricity & Elec Signals

DATA I/O CORP (DAIO) is a healthcare company in the Instruments For Meas & Testing Of Electricity & Elec Signals industry, with a market capitalization of $25 million. Shares last traded at $2.43, 45.6% below their 52-week high. Over the past year the stock is down 28.2%. Net profit margin is -50.1%, below the peer median of 2.5%. Revenue declined 1.2% year over year.

Market Cap
$25M
Shares Out
10.4M
EPS (TTM)
-$0.95
P/E (TTM)*
—
P/S Ratio
1.42
P/B Ratio
2.13
Dividend / Share
—
Dividend Yield
—
52-Week High
$4.47
52-Week Low
$2.18
Volume (venue)
13
Avg Vol (3m, venue)
987.079

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
+0.41%
1M
-17.06%
3M
-20.85%
6M
-2.99%
YTD
-23.58%
1Y
-28.21%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
35.75
SMA (50)
$2.80
SMA (200)
$3.02
Price vs SMA50
-13.14%
Price vs SMA200
-19.46%
ATR (14)
$0.09

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$18M
Net Income
-$9M
Gross Margin
50.6%
Operating Margin
-43.7%
Net Margin
-50.1%
Return on Equity
-75.2%
Return on Assets
-36.2%
Current Ratio
1.93
Debt / Equity
—
Revenue Growth (YoY)
-1.2%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 -$0.17 2026-08-14
Q1 2026 -$0.34 2026-05-15
Q4 2025 (derived) -$0.29 2026-04-16
FY 2025 -$0.56 2026-04-16
Q3 2025 -$0.15 2025-11-12
Q2 2025 -$0.08 2025-08-12

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Instruments For Meas & Testing Of Electricity & Elec Signals peers

DAIO vs 10 industry peers (Instruments For Meas & Testing Of Electricity & Elec Signals), by market cap. Data as of close

P/S vs peers
1.42 / 3.38 med
-58% discount
Net margin vs peers
-50.1% / 2.5% med
below median
1–10 of 10
TERTeradyne$42.0B30.608.4027.5%+3.17%
VLTOVeralto$28.3B28.234.8817.3%+0.52%
ITRIItron, Inc.$4.3B15.391.8612.1%-1.58%
COHUCohu Inc$2.4B—4.16-4.0%+3.43%
AEHRAehr Test Systems$2.1B—42.44-14.3%+26.45%
ALNTAllient Inc$1.5B52.382.615.0%+4.69%
TRNSTranscat Inc$837M182.362.301.3%+1.39%
FEIMFREQUENCY ELECTRONICS INC$749M279.7510.293.7%+1.25%
INTTINTEST CORP$185M312.731.530.5%+5.75%
DAIODATA I/O CORP$25M—1.42-50.1%+3.40%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.